John Bernard Payne serves as Executive at Nexvet Biopharma plc, where they oversee executive responsibilities. Since joining the company, John Bernard Payne has executed 12 insider transactions totaling $23.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 19, 2022 involved purchasing 57 shares valued at $143.
John Bernard Payne currently holds 9,401 shares of Nexvet Biopharma plc (NVET), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Bernard Payne has been a net buyer of NVET stock. They have purchased $23.1K and sold $0 worth of shares.
John Bernard Payne's most recent insider trade was on Dec 19, 2022, when they purchased 57 shares at $2.50 per share.
Get notified when new Form 4 filings are submitted
| $2.50 |
| Discretionary |
| Jan 25, 2022 | ZIVO | $22.8K | Purchase | 9,122 | $2.50 | Discretionary |
| Sep 9, 2020 | ZIVO | $25.0K | Option Exercise | 250,000 | $0.10 | Discretionary |
| Sep 9, 2020 | ZIVO | $25.9K | Payment | 235,849 | $0.11 | Discretionary |
| Jul 31, 2017 | NVET | $72.6K | Disposition | 10,800 | $6.72 | Discretionary |
| Jul 31, 2017 | NVET | $41.6K | Disposition | 6,195 | $6.72 | Discretionary |
| Jul 1, 2017 | NVET | $468 | Option Exercise | 3,600 | $0.13 | Discretionary |
| Jul 1, 2016 | NVET | $468 | Option Exercise | 3,600 | $0.13 | Discretionary |
| Jul 1, 2016 | NVET | $468 | Option Exercise | 3,600 | $0.13 | Discretionary |
| Jun 30, 2015 | NVET | $117 | Option Exercise | 900 | $0.13 | Discretionary |
| May 18, 2015 | NVET | $117 | Option Exercise | 900 | $0.13 | Discretionary |